Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study [0.03%]
Belumosudil作为类固醇依赖型/抵抗型慢性移植物抗宿主病二线或后续治疗的长期随访：一项日本研究的临床结果
Koji Kato,Yoshihiro Inamoto,Toshiro Kawakita et al.
Koji Kato et al.
Usage of rabbit anti-thymocyte / anti-T-lymphocyte globulins (ATG / ATLG) for hematological malignancies in allogeneic hematopoietic cell transplantation: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines Committee [0.03%]
EBMT实践协调和指南委员会关于兔抗胸腺细胞/抗T淋巴细胞球蛋白(ATG/ATLG)用于allo-HSCT治疗血液系统恶性肿瘤的最佳用药实践推荐
Giorgia Battipaglia,Claudia Wehr,Rick Admiraal et al.
Giorgia Battipaglia et al.
Rabbit anti-thymocyte globulin (ATG) and anti-T-lymphocyte globulin (ATLG) are widely used in allogeneic hematopoietic cell transplantation (allo-HCT) to prevent graft rejection and reduce the risk of graft-versus-host disease. Despite thei...
Incidence and risk factors for graft failure after allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis [0.03%]
异基因造血干细胞移植后原发和继发移植物抗宿主病的危险因素分析及非重型再生障碍性贫血患者预处理方案的优化研究
Yuqian Sun,Jun Zhu,Jia Chen et al.
Yuqian Sun et al.
Graft failure (GF) is a barrier to successful allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with myelofibrosis (MF). We investigated the incidence, risk factors, and prognosis for GF after allo-HSCT for MF. Two ...
Donor selection in PTCy haploidentical transplant for acute lymphoblastic leukemia: a study from the ALWP of the EBMT [0.03%]
EBMT急性淋巴细胞白血病工作组异基因半相合PTCy移植供者选择的研究
Jaime Sanz,Allain-Thibeault Ferhat,Anna Maria Raiola et al.
Jaime Sanz et al.
Haploidentical hematopoietic cell transplantation (HCT) is widely used in high-risk acute lymphoblastic leukemia (ALL), yet optimal donor selection remains unclear. We retrospectively analyzed 933 ALL patients receiving post-transplant cycl...
Hematopoietic cell transplantation in first relapse of (CBF- and other) AML [0.03%]
急性髓系白血病首次复发造血细胞移植(CBF和其他)
Edward A Copelan,Robert P Gale
Edward A Copelan
Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia [0.03%]
急性髓系白血病异基因移植前可测量的NPM1突变残余病负荷
Rasha W Al-Ali,Gege Gui,Niveditha Ravindra et al.
Rasha W Al-Ali et al.
Neglected tropical diseases (NTDs) and related infections in hematopoietic cellular therapy (HCT) in adults and children: a survey from the Infectious Diseases Working Party (IDWP) of the European Society of Blood and Marrow Transplantation (EBMT) [0.03%]
造血细胞治疗中的 neglected 热带病（NTDs）及相关感染：欧洲血液和骨髓移植学会(IDWP EBMT)调查报告
John A Snowden,Vivak Parkash,Nina Knelange et al.
John A Snowden et al.
Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMT [0.03%]
异基因造血干细胞移植治疗原发难治性急性髓系白血病的供者类型对预后的影响：欧洲血液和骨髓移植联盟急髓联盟报告
Kordelia Barbullushi,Myriam Labopin,Nicolaus Kröger et al.
Kordelia Barbullushi et al.
Primary refractory acute myeloid leukemia (prAML) is a poor prognosis disease, with allogeneic hematopoietic stem cell transplantation (allo-HSCT) being the only potentially curative option. We retrospectively evaluated outcomes in 1574 adu...
Combination ruxolitinib, belumosudil, and axatilimab yields clinically significant symptomatic improvements in treatment-refractory chronic GVHD [0.03%]
鲁索利替尼、贝马洛苏迪和阿萨替林联合治疗难治性慢性移植物抗宿主病具有显著的临床改善症状的效果
Jean Caputo,Ayush Peddireddi,Sarah Wall et al.
Jean Caputo et al.
Impact of busulfan- versus treosulfan-based conditioning on the incidence of sinusoidal obstruction syndrome/veno-occlusive disease after allogeneic hematopoietic cell transplantation: a dual-center real-world study [0.03%]
基于 busesulfan-和treosulphan-预处理对allo-HSCT后肝小静脉闭塞性病发病风险的影响：一项来自两家移植中心的真实世界研究
Lorenzo Lazzari,Aitana Balaguer-Roselló,Alessandro Bruno et al.
Lorenzo Lazzari et al.